Department of Chemistry, Rutgers University, 73 Warren Street, Newark, New Jersey 07102, United States.
Medicine Design, Pfizer, Inc., Groton, Connecticut 06340, United States.
Org Lett. 2022 Mar 4;24(8):1678-1683. doi: 10.1021/acs.orglett.2c00267. Epub 2022 Feb 24.
Heteroaromatic biaryls are core scaffolds found in a plethora of pharmaceuticals; however, their direct synthesis by the Suzuki cross-coupling is limited to heteroaromatic halide starting materials. Here, we report a direct synthesis of diverse nitrogen-containing heteroaromatic biaryls by Pd-catalyzed decarbonylative Suzuki cross-coupling of widely available heterocyclic carboxylic acids with arylboronic acids. The practical and modular nature of this cross-coupling enabled the straightforward preparation of >45 heterobiaryl products using pyridines, pyrimidines, pyrazines, and quinolines in excellent yields. We anticipate that the modular nature of this protocol will find broad application in medicinal chemistry and drug discovery research.
杂芳基联苯是许多药物中存在的核心支架,但它们通过 Suzuki 交叉偶联直接合成仅限于杂芳基卤化物起始原料。在这里,我们报告了通过 Pd 催化的广泛可用的杂环羧酸与芳基硼酸的脱羰基Suzuki 交叉偶联,直接合成各种含氮杂芳基联苯。这种交叉偶联的实用和模块化性质使得可以使用吡啶、嘧啶、吡嗪和喹啉,以优异的收率轻松制备超过 45 种杂联苯产物。我们预计该协议的模块化性质将在药物化学和药物发现研究中得到广泛应用。